STEVE WIGGINTON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEVE WIGGINTON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVE WIGGINTON. STEVE WIGGINTON is Executive Vice President in NEOFORMA INC ($NEOF) and CEO, Valence Health in Evolent Health, Inc. ($EVH) and Chief Development Officer in Evolent Health, Inc. ($EVH).
Latest Insider Trading Transactions of STEVE WIGGINTON
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 06 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Option Exercise | M | 3.84 | 6,000 | 23,040 | 405,680 | |
| Jul 06 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Sell | S | 25.07 | 6,000 | 150,420 | 12,411 | 18.4 K to 12.4 K (-32.59 %) |
| Jul 06 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Buy | M | 3.84 | 6,000 | 23,040 | 18,411 | 12.4 K to 18.4 K (+48.34 %) |
| Jun 08 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Sell | S | 25.75 | 959 | 24,694 | 12,411 | 13.4 K to 12.4 K (-7.17 %) |
| Jun 05 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Option Exercise | M | 3.84 | 6,000 | 23,040 | 411,680 | |
| Jun 05 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Sell | S | 24.36 | 4,400 | 107,184 | 13,370 | 17.8 K to 13.4 K (-24.76 %) |
| Jun 05 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Sell | S | 23.51 | 1,600 | 37,616 | 17,770 | 19.4 K to 17.8 K (-8.26 %) |
| Jun 05 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Buy | M | 3.84 | 6,000 | 23,040 | 19,370 | 13.4 K to 19.4 K (+44.88 %) |
| May 23 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Sell | S | 24.30 | 13,640 | 331,452 | 13,370 | 27 K to 13.4 K (-50.50 %) |
| May 03 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Option Exercise | M | 3.84 | 6,000 | 23,040 | 417,680 | |
| May 03 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Sell | S | 23.10 | 6,000 | 138,600 | 358,704 | 364.7 K to 358.7 K (-1.65 %) |
| May 03 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Buy | M | 3.84 | 6,000 | 23,040 | 364,704 | 358.7 K to 364.7 K (+1.67 %) |
| Apr 05 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Option Exercise | M | 3.84 | 6,000 | 23,040 | 423,680 | |
| Apr 05 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Sell | S | 23.41 | 700 | 16,387 | 358,704 | 359.4 K to 358.7 K (-0.19 %) |
| Apr 05 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Sell | S | 23.11 | 5,300 | 122,483 | 359,404 | 364.7 K to 359.4 K (-1.45 %) |
| Apr 05 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Buy | M | 3.84 | 6,000 | 23,040 | 364,704 | 358.7 K to 364.7 K (+1.67 %) |
| Mar 07 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Sell | S | 20.20 | 988 | 19,958 | 358,704 | 359.7 K to 358.7 K (-0.27 %) |
| Mar 03 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Option Exercise | M | 3.84 | 6,000 | 23,040 | 429,680 | |
| Mar 03 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Sell | S | 20.11 | 6,000 | 120,660 | 359,692 | 365.7 K to 359.7 K (-1.64 %) |
| Mar 03 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Buy | M | 3.84 | 6,000 | 23,040 | 365,692 | 359.7 K to 365.7 K (+1.67 %) |
| Feb 17 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Option Exercise | M | 3.84 | 12,000 | 46,080 | 435,680 | |
| Feb 17 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Sell | S | 20.13 | 6,000 | 120,780 | 359,692 | 365.7 K to 359.7 K (-1.64 %) |
| Feb 17 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Sell | S | 20.12 | 6,000 | 120,720 | 365,692 | 371.7 K to 365.7 K (-1.61 %) |
| Feb 17 2017 | EVH | Evolent Health, In ... | WIGGINTON STEVE | CEO, Valence Health | Buy | M | 3.84 | 12,000 | 46,080 | 371,692 | 359.7 K to 371.7 K (+3.34 %) |
| Sep 15 2016 | EVH | Evolent Health, In ... | WIGGINTON STEVE | Chief Development O ... | Sell | S | 21.54 | 45,760 | 985,670 | 359,692 | 405.5 K to 359.7 K (-11.29 %) |
| Mar 03 2016 | EVH | Evolent Health, In ... | WIGGINTON STEVE | Chief Development O ... | Option Exercise | A | 10.27 | 14,065 | 144,448 | 494,882 | |
| Mar 03 2016 | EVH | Evolent Health, In ... | WIGGINTON STEVE | Chief Development O ... | Grant | A | 0.00 | 6,329 | 0 | 73,758 | 67.4 K to 73.8 K (+9.39 %) |
| Feb 24 2004 | NEOF | NEOFORMA INC | WIGGINTON STEVE | Executive Vice Pres ... | Option Exercise | A | 11.10 | 45,200 | 501,720 | 45,200 | |
| Feb 24 2004 | NEOF | NEOFORMA INC | WIGGINTON STEVE | Executive Vice Pres ... | Grant | A | 0.00 | 20,900 | 0 | 71,569 | 50.7 K to 71.6 K (+41.25 %) |
Page: 1